Clinical Trial Update: A Multi-center, Observer-blind, Placebo-controlled, Randomized Study to Evaluate the Immunogenicity and Safety of MenACWY in Adolescents and Adults in Korea [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated the immunogenicity and safety of the MenACWY meningococcal conjugate vaccine in adolescents and adults in Korea, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease
• Meningococcal Meningitis

Drugs mentioned

• MenACWY (Meningococcal conjugate vaccine A/C/W-135/Y)

Snippet

Sponsor: Novartis Vaccines | Conditions: Meningococcal Disease, Meningococcal Meningitis | Phase 3 | Status: COMPLETED | Results posted: 2012-10-16